T 2177/12 () of 24.7.2013

European Case Law Identifier: ECLI:EP:BA:2013:T217712.20130724
Date of decision: 24 July 2013
Case number: T 2177/12
Application number: 06751411.7
IPC class: A61M 39/02
A61M 39/04
Language of proceedings: EN
Distribution: D
Download and more information:
Decision text in EN (PDF, 161.790K)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: Power injector system for injecting contrast media into an intravenous line
Applicant name: C.R.Bard, Inc.
Opponent name: AESCULAP AG & Co. KG
Fresenius Kabi Deutschland GmbH
pfm medical ag
Board: 3.2.02
Headnote: -
Relevant legal provisions:
European Patent Convention Art 68
European Patent Convention Art 101
European Patent Convention Art 105a
European Patent Convention Art 107
European Patent Convention Art 112(1)
European Patent Convention Art 113(2)
Rules of procedure of the Boards of Appeal Art 16(1)(e)
European Patent Convention R 71(3)
European Patent Convention R 91
Keywords: Adversely affected (no)
Admissibility of the appeal (no)
Referral to Enlarged Board (no)
Apportionment of costs (no)
Catchwords:

-

Cited decisions:
G 0009/93
T 0329/88
T 0961/00
T 0655/01
Citing decisions:
T 0220/12
T 0964/14

16 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

EPC Implementing Rules

Case Law Book: IV Divisional Applications

Case Law of the Enlarged Board

General Case Law